Neoadjuvant SABR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus—Safety Lead-in Results of a Phase 2 Trial
2021 · International Journal of Radiation Oncology*Biology*Physics · 69 citations
https://doi.org/10.1016/j.ijrobp.2021.01.054
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
16
Papers
176
Citations
5
h-index
4
i10-index
Subrata Manna is an academic researcher. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Renal cell carcinoma treatment & Cancer Genomics and Diagnostics. The author has an h-index of 5, co-authored 14 publications.
ORCID: 0000-0001-9534-3935Click to start Chat